Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Trends in Cancer|March 23, 2019
Born to Kill: NK Cells Go to War against CancerErik Wennerberg, Lorenzo GalluzziMethods in Enzymology|March 18, 2020
Isolation of DNA from exosomesSheila Spada, Nils-Petter Rudqvist, Erik WennerbergMethods in Enzymology|March 4, 2020
Characterization of conventional dendritic cell populations in preclinical tumor models using flow cytometryErik Wennerberg, Nils-Petter Rudqvist, Sheila SpadaCancer Immunology, Immunotherapy : CII|October 27, 2014
CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivoErik Wennerberg, Veronika Kremer, Richard Childs, et al.Science Immunology|July 7, 2023
The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapyJohn Stagg, Encouse Golden, Erik Wennerberg, et al.Oncoimmunology|May 23, 2022
The ART of tumor immune escapeErik Wennerberg, Sumit Mukherjee, Ricardo M Sainz, et al.Oncology (Williston Park, N.Y.)|December 18, 2015
Exercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and ProgressionGraeme J Koelwyn, Erik Wennerberg, Sandra Demaria, et al.Immunology Letters|September 8, 2014
Dysregulated Fc receptor function in active rheumatoid arthritisSofia E Magnusson, Erik Wennerberg, Peter Matt, et al.Cancer Journal (Sudbury, Mass.)|August 6, 2025
Modulating Purinergic Signaling to Improve Radiotherapy OutcomesJessica Oliver, Victor Gray, Linda S Li, et al.Cancer Immunology, Immunotherapy : CII|May 22, 2013
A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cellsDhifaf Sarhan, Erik Wennerberg, Padraig D'Arcy, et al.Pageof 4